Very clever Using the COVID-19 to mislead investors is very clever. But we all know that it won't last.
Sorry to disturb your enthusiasm...
The reality is :
No news
No Ryplazim approval
No partnership
No analyst coverage
only speculation... burning rate and dilution as always.
We have been there many times since 1994
LOL